CTSA

Gordon Bernard, MD, is stepping down from his institutional leadership roles next summer to focus on his research interests.
December 16, 2022

VUMC Announces VICTR Leadership Transition

By Bill Snyder
November 17, 2022

Study supports removing race from estimate of kidney function

An in-depth analysis by Vanderbilt investigators of published research studies supports removing race from the calculation of estimated glomerular filtration rate (eGFR) — an assessment of kidney function.

By Leigh MacMillan
September 22, 2022

Self named co-principal investigator of Vanderbilt’s Clinical and Translational Science Award

Wesley Self, MD, MPH, a physician-scientist at Vanderbilt University Medical Center, has been named co-principal investigator (co-PI) of Vanderbilt’s Clinical and Translational Science Award (CTSA).  

By Bill Snyder
VUMC’s new automated biobanking system can store as many as 10 million biospecimens.
April 6, 2022

Major grant renewal to provide five more years of support for VICTR

Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.

By Bill Snyder
August 21, 2020

VUMC awarded $34 million to lead nationwide convalescent plasma study

Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.

By Bill Snyder
January 16, 2020

Wilkins named CTSA co-principal investigator

Consuelo Wilkins, MD, MSCI, has joined Gordon Bernard, MD, as co-principal investigator of Vanderbilt’s Clinical and Translational Science Award.

By Bill Snyder
September 6, 2017

Heat a trigger for seizures

Elevated body temperature alone can increase vulnerability to fever-induced seizures, even in the absence of infection or inflammation.
By Sanjay Mishra
September 5, 2017

Pain and Alzheimer’s disease

Clinicians should use a structured interview in people with Alzheimer’s disease to identify pain that might be otherwise overlooked.
By VUMC News and Communications
June 8, 2017

VUMC lands renewal of Clinical and Translational Science Award

Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH).
By Bill Snyder
June 24, 2016

Superior scan for tumors

Imaging with a compound that binds to neuroendocrine cells is a safer and more effective way to detect rare neuroendocrine tumors.
By Bill Snyder
November 16, 2015

Children, heart disease, and IQ

Treatment for congenital heart disease during infancy may result in cognitive and attentional deficits during adolescence and young adulthood, Vanderbilt researchers have found.
By VUMC News and Communications
October 22, 2015

Revised regulations proposed for human subject research

Eighteen departments and agencies of the federal government have joined to propose revised regulations for scientific research involving human subjects.
By Paul Govern
April 30, 2014

Potential mechanism for myeloma drug’s variable toxicity

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.
By Leigh MacMillan
1 2